Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia.

Autor: Cellini, Alessandro¹ (AUTHOR), Salvalaggio, Alessandro² (AUTHOR), Velasco, Roser³ (AUTHOR), Arnan, Montserrat⁴ (AUTHOR), Cacciavillani, Mario⁵ (AUTHOR), Riva, Marcello⁶ (AUTHOR), Trentin, Livio¹ (AUTHOR), Pomares, Helena⁴ (AUTHOR), Lessi, Federica¹ (AUTHOR), Briani, Chiara² (AUTHOR) chiara.briani@unipd.it

Publikováno v: Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 13, p2060-2063. 4p.

Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism.

Autor: Mazzarella L; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy luca.mazzarella@ieo.it.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Botteri E; Cancer Registry of Norway, Oslo, Norway., Matthews A; London School of Hygiene and Tropical Medicine, London, UK., Gatti E; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Di Salvatore D; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy., Bagnardi V; University of Milan-Bicocca, Milan, Italy., Breccia M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy., Montesinos P; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bernal T; Hospital Central de Asturias, Oviedo, Spain., Gil C; Hospital General, Alicante, Spain., Ley TJ; Department of Medicine, Division of Oncology, Washington University in St. Louis, Saint Louis, MO, USA., Sanz M; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bhaskaran K; London School of Hygiene and Tropical Medicine, London, UK., Coco FL; Department of Hematology, University Tor Vergata, Roma, Italy., Pelicci PG; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy piergiuseppe.pelicci@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milan.

Publikováno v: Haematologica [Haematologica] 2020 Jun; Vol. 105 (6), pp. 1559-1566. Date of Electronic Publication: 2019 Sep 12.

Characterization of a recurrent translocation t(2;3)(pl5-22;q26) occurring in acute myeloid leukemia

Autor: Trubia, M, Albano, F, Cavazzini, Francesco, Cambrin, Gr, Quarta, G, Fabbiano, F, Ciambelli, F, Magro, D, Hernandez, Jm, Mancini, M, Diverio, D, Pelicci, Pg, Coco, Fl, Mecucci, C, Specchia, G, Rocchi, M, Liso, V, Castoldi, Gianluigi, Cuneo, Antonio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3709::e36a337aad90b9fe8e3979c707aa896d
http://hdl.handle.net/11392/1199388

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.

Autor: Sanarico AG; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Ronchini C; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia, Milan, Italy., Croce A; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Memmi EM; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy., Cammarata UA; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy., De Antoni A; The FIRC Institute of Molecular Oncology Foundation-IFOM, Milan, Italy., Lavorgna S; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy., Divona M; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy., Giacò L; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy., Melloni GEM; Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia, Milan, Italy., Brendolan A; Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute, Milan, Italy., Simonetti G; Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy., Martinelli G; Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy., Mancuso P; Laboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy., Bertolini F; Laboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy., Coco FL; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy., Melino G; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.; Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK., Pelicci PG; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, Milan University, Milan, Italy., Bernassola F; Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.

Publikováno v: Leukemia [Leukemia] 2018 Apr; Vol. 32 (4), pp. 911-919. Date of Electronic Publication: 2017 Dec 06.

P53 GENE INACTIVATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA OF B-CELL LINEAGE ASSOCIATES WITH CHROMOSOMAL BREAKPOINTS AT 11Q23 AND 8Q24

Autor: Lanza, C, Gaidano, G, Cimino, Giuseppe, Coco, Fl, Basso, G, Sainati, L, Pastore, C, Nomdedeu, J, Volpe, G, Parvis, G, Barisone, E, Mazza, U, Madon, E, Saglio, G.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::0f99220580cd2475a4b4677064cc7f72
http://hdl.handle.net/11573/501072